Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab
Recruiting
N/A
Interventional Study
Breast Cancer
Anthracycline Related Cardiotoxicity in Breast Cancer
Virtual Reality
Trastuzumab
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 30 (estimated)
- Sponsor
- Virginia Commonwealth University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The main goal of this study is to test a virtual reality (VR) program, Survivors' Virtual Reality Survivorship Experience (SurviVRSE), designed to help Breast Cancer survivors (n=30) learn about heart health. The aims are to test the usability, feasibility, and acceptability o the intervention. Additionally, follow-up assessments will examine changes in women's cancer therapy related cardiac dysfu…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* 18 years of age or older
* Able to speak and read in English
* Actively receiving Trastuzumab or an anthracycline-based treatment
* Currently receiving immunotherapy. This includes pembrolizumab and atezolizumab.
* Diagnosed with stages 0-III Breast Cancer
Exclusion Criteria:…
Contacts